OUP Management as of Sept. 30, 2022
Portfolio Holdings for OUP Management
OUP Management holds 15 positions in its portfolio as reported in the September 2022 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Centessa Pharmaceuticals Sponsored ADS (CNTA) | 18.4 | $12M | 2.9M | 4.02 | |
PMV Pharmaceuticals Common Stock (PMVP) | 18.3 | $12M | 989k | 11.90 | |
DICE Therapeutics Common Stock | 16.9 | $11M | 537k | 20.28 | |
Aerovate Therapeutics Common Stock (AVTE) | 15.6 | $10M | 604k | 16.58 | |
ionQ Common Stock (IONQ) | 9.3 | $6.0M | 1.2M | 5.07 | |
Cyteir Therapeutics Common Stock | 7.4 | $4.7M | 2.5M | 1.92 | |
Vor Biopharma Common Stock (VOR) | 2.3 | $1.5M | 375k | 3.98 | |
Precision BioSciences Common Stock | 2.3 | $1.5M | 1.1M | 1.30 | |
Selecta Biosciences Common Stock (RNAC) | 2.2 | $1.4M | 863k | 1.64 | |
Evolv Technologies Holdings Common Stock (EVLV) | 2.2 | $1.4M | 653k | 2.12 | |
Graphite Bio Common Stock | 2.0 | $1.3M | 406k | 3.17 | |
Landos Biopharma Common Stock | 1.3 | $804k | 1.2M | 0.65 | |
eFFECTOR Therapeutics Common Stock | 0.9 | $587k | 1.0M | 0.57 | |
Spero Therapeutics Common Stock (SPRO) | 0.8 | $498k | 249k | 2.00 | |
Homology Medicines Common Stock | 0.2 | $103k | 64k | 1.61 |